Health Canada approves 1st generic version of Ozempic in the country [Yahoo! Finance Canada]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Yahoo! Finance Canada
The injectable medication is manufactured by Dr. Reddy's Laboratories in India and is approved for the once-weekly treatment of Type 2 diabetes in adults. In a news release, Health Canada says many generic medications are 45 to 90 per cent cheaper than brand-name versions. Many people without drug coverage have been eagerly waiting for generic semaglutide because Novo Nordisk's Ozempic can cost hundreds of dollars a month. Although those medications are approved for diabetes treatment, they are often prescribed off-label for weight loss. Health Canada says it continues to review eight other generic semaglutide submissions from other companies. How much cheaper generic semaglutide will be than Ozempic depends on how many generic options are approved and hit the market, said Mina Tadrous, a pharmaceutical policy expert at the University of Toronto. According to the pricing structure of the pan-Canadian Pharmaceutical Alliance, the first generic medication could cost 75 to 8
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Meta is heading into earnings with a big move expected [Yahoo! Finance]Yahoo! Finance
- Canada approves generic version of Novo's Ozempic [Seeking Alpha]Seeking Alpha
- Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in CanadaBusiness Wire
- Health Canada approves 1st generic version of Ozempic in the country [BNN Bloomberg (Canada)]BNN Bloomberg
- Dr. Reddy's Laboratories (RDY) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c)" to "hold (c+)".MarketBeat
RDY
Earnings
- 1/22/26 - Beat
RDY
Sec Filings
- 4/29/26 - Form 6-K
- 4/24/26 - Form 6-K
- 4/24/26 - Form 6-K
- RDY's page on the SEC website